SEC EDGAR published this disclosure on 2026-09-10. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001643653-26-000016
acquired disposedD
codeS
direct or indirectD
form4
is derivativefalse
issuer nameNEUROCRINE BIOSCIENCES INC
labelOpen market sale
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001643653-26-000016",
"acquired_disposed": "D",
"code": "S",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "NEUROCRINE BIOSCIENCES INC",
"label": "Open market sale",
"person_name": "BENEVICH ERIC",
"price": 154.61,
"role": "Chief Commercial Officer",
"security": "Common Stock",
"shares": 2154,
"shares_owned_after": 64408,
"source_path": "edgar/data/1643653/0001643653-26-000016.txt",
"ticker": "NBIX",
"transaction_date": "2026-09-09",
"value": 333029.94
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.